AQST
USDAquestive Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$6.410
Haut
$6.410
Bas
$5.790
Volume
3.85M
Fondamentaux de l'Entreprise
Capitalisation Boursière
736.9M
Industrie
Drug Manufacturers - Specialty & Generic
Pays
United States
Statistiques de Trading
Volume Moyen
3.10M
Bourse
NGM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company's ongoing development initiatives Matthew Davis, M.D.,
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
WARREN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
WARREN, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
WARREN, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients'
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.